Atlas Trials

HAIC Combined With Donafenib Tosilate and Toripalimab for Unresectable HCC

Clinical trial NCT05493332 · UNKNOWN

Trial details

NCT number
NCT05493332
Sponsor
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Hepatocellular Carcinoma
Start date
2022-09-01
Primary completion
2023-09-01
Enrollment
93

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.